Literature DB >> 34839363

Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants.

Sarah D Lichenstein1, Nick Manco2, Lora M Cope3, Leslie Egbo4, Kathleen A Garrison5, Jillian Hardee3, Ansel T Hillmer5,6, Kristen Reeder7, Elisa F Stern8, Patrick Worhunsky5, Sarah W Yip5,9.   

Abstract

Cannabis use peaks in adolescence, and adolescents may be more vulnerable to the neural effects of cannabis and cannabis-related harms due to ongoing brain development during this period. In light of ongoing cannabis policy changes, increased availability, reduced perceptions of harm, heightened interest in medicinal applications of cannabis, and drastic increases in cannabis potency, it is essential to establish an understanding of cannabis effects on the developing adolescent brain. This systematic review aims to: (1) synthesize extant literature on functional and structural neural alterations associated with cannabis use during adolescence and emerging adulthood; (2) identify gaps in the literature that critically impede our ability to accurately assess the effect of cannabis on adolescent brain function and development; and (3) provide recommendations for future research to bridge these gaps and elucidate the mechanisms underlying cannabis-related harms in adolescence and emerging adulthood, with the long-term goal of facilitating the development of improved prevention, early intervention, and treatment approaches targeting adolescent cannabis users (CU). Based on a systematic search of Medline and PsycInfo and other non-systematic sources, we identified 90 studies including 9441 adolescents and emerging adults (n = 3924 CU, n = 5517 non-CU), which provide preliminary evidence for functional and structural alterations in frontoparietal, frontolimbic, frontostriatal, and cerebellar regions among adolescent cannabis users. Larger, more rigorous studies are essential to reconcile divergent results, assess potential moderators of cannabis effects on the developing brain, disentangle risk factors for use from consequences of exposure, and elucidate the extent to which cannabis effects are reversible with abstinence. Guidelines for conducting this work are provided.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34839363      PMCID: PMC8938408          DOI: 10.1038/s41386-021-01226-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  131 in total

Review 1.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Lancet       Date:  2012-01-07       Impact factor: 79.321

2.  A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs.

Authors:  Arpana Agrawal; Michael C Neale; Carol A Prescott; Kenneth S Kendler
Journal:  Psychol Med       Date:  2004-10       Impact factor: 7.723

Review 3.  Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study.

Authors:  David M Fergusson; Joseph M Boden; L John Horwood
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-26       Impact factor: 4.328

Review 4.  Cannabis use, attitudes, and legal status in the U.S.: A review.

Authors:  Hannah Carliner; Qiana L Brown; Aaron L Sarvet; Deborah S Hasin
Journal:  Prev Med       Date:  2017-07-11       Impact factor: 4.018

Review 5.  Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

Authors:  Penny F Whiting; Robert F Wolff; Sohan Deshpande; Marcello Di Nisio; Steven Duffy; Adrian V Hernandez; J Christiaan Keurentjes; Shona Lang; Kate Misso; Steve Ryder; Simone Schmidlkofer; Marie Westwood; Jos Kleijnen
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

6.  Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  Catalina Lopez-Quintero; José Pérez de los Cobos; Deborah S Hasin; Mayumi Okuda; Shuai Wang; Bridget F Grant; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2010-12-08       Impact factor: 4.492

Review 7.  Adverse health effects of marijuana use.

Authors:  Nora D Volkow; Ruben D Baler; Wilson M Compton; Susan R B Weiss
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

8.  Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study.

Authors:  Carlos Blanco; Deborah S Hasin; Melanie M Wall; Ludwing Flórez-Salamanca; Nicolas Hoertel; Shuai Wang; Bradley T Kerridge; Mark Olfson
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

Review 9.  Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.

Authors:  Arianna Marconi; Marta Di Forti; Cathryn M Lewis; Robin M Murray; Evangelos Vassos
Journal:  Schizophr Bull       Date:  2016-02-15       Impact factor: 9.306

Review 10.  Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence.

Authors:  Grace Blest-Hopley; Marco Colizzi; Vincent Giampietro; Sagnik Bhattacharyya
Journal:  Front Psychiatry       Date:  2020-08-26       Impact factor: 4.157

View more
  2 in total

Review 1.  Neural substrates of substance use disorders.

Authors:  Martin P Paulus
Journal:  Curr Opin Neurol       Date:  2022-07-05       Impact factor: 6.283

2.  Effects of cannabinoid exposure on short-term memory and medial orbitofrontal cortex function and chemistry in adolescent female rhesus macaques.

Authors:  Stephen J Kohut; Lei Cao; Dionyssios Mintzopolous; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Chun S Zou; J Eric Jensen; Blaise B Frederick; Jack Bergman; Brian D Kangas
Journal:  Front Neurosci       Date:  2022-09-30       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.